Unusual rapid progression of non-bacterial thrombotic endocarditis in a patient with bladder cancer despite undergoing intensification treatment with rivaroxaban for acute venous thromboembolism | Synapse
June 15, 2026Open Access
Unusual rapid progression of non-bacterial thrombotic endocarditis in a patient with bladder cancer despite undergoing intensification treatment with rivaroxaban for acute venous thromboembolism
Key Points
The aim is to highlight an unusually fast progression of non-bacterial thrombotic endocarditis in a bladder cancer patient despite treatment.
Case report detailing the patient's clinical history, treatment regimen, and disease progression.
Patient received rivaroxaban as an intensification treatment for acute venous thromboembolism.
The patient experienced rapid deterioration of symptoms related to non-bacterial thrombotic endocarditis.
Despite rivaroxaban treatment, there was no improvement in the patient's condition, indicating treatment failure.